For the quarter ending 2026-03-31, GERN had -$8,661K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -3,642 | -28,862 | -18,428 | -36,210 |
| Depreciation and amortization | 134 | 87 | 128 | 259 |
| Accretion and amortization on investments, net | 1,069 | 1,444 | 1,529 | 3,948 |
| Amortization of debt issuance costs/debt discounts | 286 | 283 | 273 | 515 |
| Non-cash interest expense on liabilities for sales of future royalties | 3,912 | 3,905 | 5,163 | 9,880 |
| Loss of extinguishment of debt | - | 0 | - | - |
| Stock-based compensation for services by non-employees | - | 18 | 29 | 41 |
| Stock-based compensation expense | 4,913 | 5,771 | 6,742 | 14,146 |
| Amortization of right-of-use assets | 192 | 188 | 184 | 358 |
| Current and noncurrent liabilities | - | - | 21,370 | -21,484 |
| Increase in allowance for doubtful accounts | 0 | -46 | -25 | 21 |
| Inventory | 16,651 | 21,214 | 26,298 | 30,410 |
| Accounts receivable, net | 4,894 | 1,580 | -1,273 | 684 |
| Interest and other receivables | - | -614 | - | - |
| Prepaid expenses and other assets | - | -443 | - | - |
| Deposit and other assets | - | 1,865 | - | - |
| Prepaid expenses and other assets | 2,401 | - | -1,340 | 1,173 |
| Accounts payable | 1,463 | 2,661 | - | - |
| Accrued compensation and benefits | -21,009 | 7,689 | - | - |
| Accrued liabilities | -20,374 | 15,790 | - | - |
| Payments on royalty agreement | 3,721 | 3,656 | 3,798 | 6,705 |
| Operating lease liabilities | -212 | -796 | - | - |
| Net cash used in operating activities | -62,906 | -22,067 | -13,576 | -75,394 |
| Proceeds from maturities of marketable securities | - | - | 90,288 | 196,065 |
| Purchases of property and equipment | 252 | 0 | -89 | 138 |
| Purchases of marketable securities | 34,525 | 104,219 | 77,029 | 123,173 |
| Proceeds from maturities and sales of marketable securities | 86,633 | 411,717 | - | - |
| Proceeds from employee stock purchase plan | - | - | 0 | 500 |
| Net cash provided by investing activities | 51,856 | 21,145 | 13,348 | 72,754 |
| Proceeds from issuances of common stock from equity plans | 914 | 878 | 542 | 847 |
| Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs | - | 0 | 0 | 0 |
| Proceeds from the exercise of warrants | 1,511 | 0 | 0 | 0 |
| Proceeds from sale of future royalties | - | 0 | - | - |
| Proceeds from debt financing, net of paid debt issuance costs and debt discounts | - | 0 | - | - |
| Repayment of debt | - | 0 | - | - |
| Net cash provided by financing activities | 2,425 | 378 | 542 | 1,347 |
| Net effect of exchange rates on cash, cash equivalents and restricted cash | -36 | -9 | 75 | 21 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -8,661 | -553 | 389 | -1,272 |
| Cash, cash equivalents and restricted cash at the beginning of the period | 79,440 | 79,993 | 80,876 | - |
| Cash, cash equivalents and restricted cash at the end of the period | 70,779 | 79,440 | 79,993 | - |
GERON CORP (GERN)
GERON CORP (GERN)